Drug Type Gene therapy |
Synonyms ED 002(Replay Therapeutics), ED002(Replay Therapeutics) |
Target |
Mechanism MerTK inhibitors(Tyrosine-protein kinase Mer inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Replay Therapeutics, Inc.Startup |
Active Organization- |
Inactive Organization Replay Therapeutics, Inc.Startup |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Retinitis Pigmentosa | Preclinical | - | Replay Therapeutics, Inc.Startup | 08 Jan 2024 |